This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, R.-N. Articles by Broxmeyer, H. E. Search for Related Content PubMed PubMed Citation Articles by Shen, R.-N. Articles by Broxmeyer, H. E.

Curative Effect of Split Low Dosage Total-Body Irradiation on Mice Infected with the Polycythemia-inducing Strain of the Friend Virus Complex¹

Departments of Radiation Oncology [R-N. S., N. B. H.], Medicine [L. L., Z. B., H. E. B.], (Hematology/Oncology) [L. L., H. E. B.], Obstetrics/Gynecology [P. Y.], Microbiology/Immunology [Z. B., H. E. B.], and the Walther Medical Research Institute [H. E. B.], Indiana University School of Medicine, Indianapolis, Indiana 46223

Split low dose total-body irradiation (TBI) with 150 cGy was assessed for its efficacy in modifying the disease induced in DBA/2 mice by the polycythemia-inducing strain of the Friend virus complex (FVC-P, composed of a Friend murine leukemia helper virus and a spleen focusforming virus). All FVC-P injected mice were dead within 40 days; however, infected mice receiving TBI on days 5 and 12 exhibited long-term survival. FVC-P-injected mice receiving TBI treatment on days 5 and 12 had normal leukocyte counts, normal spleen weights, and no detectable spleen focus-forming virus. Although the FVC-P-infected mice had decreased proportions of L3T4⁺ cells and increased proportions of Lyt-2⁺ cells, these were returned to normal following TBI treatment. Apparently the time sequence of TBI treatments is important since one treatment with TBI on day 5, or two treatments with TBI on days 12 and 18, was not as efficacious. The inability of in vitro irradiation doses of up to 1000 cGy to inactivate FVC-P which was subsequently injected into murine hosts suggests that the effectiveness of the TBI treatment in vivo is not due to a direct radiation effect on the virus. These results indicate a possible relationship between L3T4⁺ and Lyt-2⁺ numbers or their ratio in the curative efficacy of TBI in FVC-P-infected mice.

¹ Supported by Public Health Service Grants CA 36464 and CA 36740 (H. E. B.) from the National Cancer Institute, grants from the Little Red Door, Marion County Cancer Society, Inc. (R-N. S. and L. L.), and a research grant from Phi Beta Psi sorority (L. L.).

² To whom requests for reprints should be addressed, at Department of Radiation Oncology, Indiana University School of Medicine, Radiation Therapy Building, Room 053, 535 Barnhill Drive, Indianapolis, IN 46223.

Received 10/23/87. Revised 1/18/88. Accepted 1/27/88.

This article has been cited by other articles:

				M. Kitagawa, S. Yamaguchi, M. Hasegawa, K. Tanaka, T. Sado, K. Hirokawa, and S. Aizawa Friend Leukemia Virus Infection Enhances DNA Damage-Induced Apoptosis of Hematopoietic Cells, Causing Lethal Anemia in C3H Hosts J. Virol., June 27, 2002; 76(15): 7790 - 7798. [Abstract] [Full Text] [PDF]